Tuberculosis News and Research

Latest Tuberculosis News and Research

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

10 Sep 2013

Disease Twofer: Parkin Problem Leads To Parkinson’S And Impairs Response To TB

University of California, San Francisco researchers report that a key protein associated with Parkinson's disease also plays a major role in the destruction of the bacteria that cause tuberculosis.

5 Sep 2013

Parkin protein plays key role in destruction of bacteria that cause tuberculosis

A protein at the center of Parkinson's disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis, according to scientists led by UC San Francisco microbiologist and tuberculosis expert Jeffery Cox, PhD.

5 Sep 2013

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.

3 Sep 2013

Researchers identify origin of human TB

Tuberculosis remains one of deadliest infectious diseases of humans, killing 50% of individuals when left untreated. Even today, TB causes 1-2 million deaths every year mainly in developing countries. Multidrug-resistance is a growing threat in the fight against the disease.

2 Sep 2013

New quick test promises to reduce economic, health burden of syphilis cases in Latin America

Demystifying the chemical processes that create a wine's aroma, and the invaluable potential application of that understanding in winemaking, is the new objective of scientists in Uruguay who, with European partners, also recently sequenced the genome of the high-value Tannat grape, from which "the most healthy of red wines" are fermented.

2 Sep 2013

Holistic approach to understand and treat TB

For years, physicians around the world have watched as strain after strain of the deadly bacteria Mycobacterium tuberculosis evolves resistance to drugs.

2 Sep 2013

BP and headache drug effectively speeds up treatment of TB

Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.

30 Aug 2013

Mental and substance use disorders responsible for more death and illness worldwide

Mental and substance use disorders were the leading cause of non-fatal illness worldwide in 2010, according to a new analysis from the Global Burden of Disease Study, published in The Lancet.

29 Aug 2013

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed - a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

29 Aug 2013

Barber pole worm genome provides essential platform to understand drug resistance in worms

Researchers have identified five enzymes that are essential to the survival of a parasitic worm that infects livestock worldwide and is a great threat to global food security. Two of these proteins are already being studied as potential drug targets against other pathogens.

29 Aug 2013

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

Cepheid today announced the U.S. Food & Drug Administration has categorized Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments.

28 Aug 2013

New polymer additives enhance ability of oral drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed — a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

28 Aug 2013

Engineers create biodegradable needles that penetrate skin and precisely deliver tuberculosis test

Each year, millions of people in the United States get a tuberculosis skin test to see if they have the infection that still affects one third of the world's population. But the standard diagnostic test is difficult to give, because a hypodermic needle must be inserted at a precise angle and depth in the arm to successfully check for tuberculosis.

27 Aug 2013

Researchers request all countries to record smoking on death registries

Researchers today [Friday 23 August] call for official death registries in all countries to record whether the dead person was a smoker, in a research Article published in The Lancet.

23 Aug 2013

Mentors International, Co-Diagnostics HBDC to lower real-time PCR test prices in developing world

Mentors International and Co-Diagnostics HBDC signed an agreement to lower real-time PCR test prices in the developing world, starting with tuberculosis. Under the agreement, Co-Diagnostics HBDC will provide low-cost testing reagents and Mentors International will leverage its international connections to set up low-cost testing facilities.

23 Aug 2013

Scientists reveal why TB is a successful pathogen

By any measure, tuberculosis is a wildly successful pathogen. It infects as many as two billion people in every corner of the world, with a new infection of a human host estimated to occur every second.

22 Aug 2013

UC Davis Health System develops new screening strategy for lethal stage of TB in Asia

More than 20,000 people in Pakistan are being tested for the potentially deadly stage of tuberculosis using a new strategy developed at UC Davis Health System to effectively detect the disease in children for the first time.

22 Aug 2013

Study shows ART has reduced immunosuppression and viremia among PHIV youth

The advent of antiretroviral therapy (ART) has transformed HIV from a death sentence into a chronic disease. In one of the largest studies of perinatally infected HIV (PHIV) patients to date, Agwu, et al, found that the proportion of patients on ART has increased and rates of viremia and advanced immunosuppression have decreased. But the rates of both markers in older patients are higher, according to an article in the Fall issue of The Journal of the Pediatric Infectious Diseases Society (JPIDS).

20 Aug 2013

Preventive antibiotics for HIV patients lower risk of TB or death

As part of the largest international research effort ever made to combat tuberculosis, a team of Johns Hopkins and Brazilian experts has found that preventive antibiotic therapy for people with HIV lowers this group's chances of developing TB or dying.

16 Aug 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Disease Twofer: Parkin Problem Leads To Parkinson’S And Impairs Response To TB

Parkin protein plays key role in destruction of bacteria that cause tuberculosis

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Researchers identify origin of human TB

New quick test promises to reduce economic, health burden of syphilis cases in Latin America

Holistic approach to understand and treat TB

BP and headache drug effectively speeds up treatment of TB

Mental and substance use disorders responsible for more death and illness worldwide

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

Barber pole worm genome provides essential platform to understand drug resistance in worms

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

New polymer additives enhance ability of oral drugs to reach bloodstream

Engineers create biodegradable needles that penetrate skin and precisely deliver tuberculosis test

Researchers request all countries to record smoking on death registries

Mentors International, Co-Diagnostics HBDC to lower real-time PCR test prices in developing world

Scientists reveal why TB is a successful pathogen

UC Davis Health System develops new screening strategy for lethal stage of TB in Asia

Study shows ART has reduced immunosuppression and viremia among PHIV youth

Preventive antibiotics for HIV patients lower risk of TB or death

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in